Strengthening the four foundations under the Sixth Medium-Term Management Plan
First written in FY2017. 7 of 14 entries say "Restated". Latest entry: FY2026.
Bml moved to the "Worse" side of this theme in 2022, the same year as the typical company in this theme.
The whole theme swung hardest in 2024: 8 of 42 companies on the "Worse" side.
18 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Under “building next-generation laboratories,” the new testing building at BML Food Science, Phase 6 of the BML General Research Institute building, and the new Tokyo laboratory of PCL Japan became operational. This will enable sustainable expansion of testing capacity for the next 10 years.」
Regarding the next-generation laboratories at the core of the Ninth Medium-Term Management Plan, the company reported concrete progress through the launch of 3 facilities and expansion of testing capacity for the next 10 years. - 2026-05-13RestatedResults
「2024年度から第９次中期経営計画（2024～2028年度）がスタートしました。この第９次中期経営計画では、グループビジョンの実現に向けて「さらなる品質」、「ソリューション」および「相互の発展」の追求をキーコンセプトとし、「10年先を見据えた事業拡大を確固たるものにする」ことを目標に、事業の成長を維持しつつ集中投資による事業基盤の大幅な拡充を同時並行で進めてまいります。」
第9次中期経営計画の期間、キーコンセプト、10年先を見据えた事業拡大と集中投資の方針を再確認している。 - FY2025AdvancedAnnual report
「Specifically, the company will advance the plan based on 6 basic strategic frameworks centered on “building next-generation laboratories”: “expanding sales and market share,” “improving profitability,” “optimizing the business portfolio,” “strengthening service levels,” “promoting standardization,” and “developing advanced testing.”」
The company provided details of the 6 basic strategies under the Ninth Medium-Term Management Plan and reported progress on the plan through the launch of next-generation laboratories. - FY2024ReframedAnnual report
「The Ninth Medium-Term Management Plan (fiscal 2024 to fiscal 2028) will start in fiscal 2024. With “further quality,” “solutions,” and “mutual development” as its key concepts for realizing the Group vision, the plan aims to “firmly establish business expansion with a view to the next 10 years.” While maintaining business growth, the company will also substantially expand its business foundation through focused investment.」
The company changed from the Eighth Medium-Term Management Plan to the Ninth Medium-Term Management Plan (fiscal 2024 to fiscal 2028), placing business expansion with a view to the next 10 years and focused investment at the core of the new plan. - FY2022ReframedAnnual report
「Fiscal 2022 is the second year of the Ninth Medium-Term Management Plan (fiscal 2021 to fiscal 2023), a medium-term plan developed as part of a nine-year plan. The company positions this period as the leap phase for its Group vision of “Becoming a company trusted and chosen by the medical community,” and will further advance the improvements in quality and services pursued since the Sixth Medium-Term Management Plan. The Eighth Medium-Term Management Plan sets out 3 missions.」
The company changed from the Seventh Medium-Term Management Plan to the Eighth Medium-Term Management Plan and, in the second year of the fiscal 2021 to fiscal 2023 plan, set out 3 missions: customer satisfaction, synergies, and social responsibility. - FY2020AdvancedAnnual report
「Fiscal 2020 is the final year of the Seventh Medium-Term Management Plan (fiscal 2018 to fiscal 2020). The Seventh Medium-Term Management Plan positions this period as the growth phase for the Group vision of “Becoming a company trusted and chosen by the medical community.” While further advancing the initiatives of the Sixth Medium-Term Management Plan, the company will also address new challenges.」
The Seventh Medium-Term Management Plan has entered its final year after its first and second years, and the company has positioned itself to continue advancing its previous initiatives and addressing new challenges. - FY2019RestatedAnnual report
「Fiscal 2019 is the second year of the Seventh Medium-Term Management Plan (fiscal 2018 to fiscal 2020). The Seventh Medium-Term Management Plan positions this period as the growth phase for the Group vision of “Becoming a company trusted and chosen by the medical community.” While further advancing the initiatives of the Sixth Medium-Term Management Plan, the company will also address new challenges.」
As the second year of the Seventh Medium-Term Management Plan, the company continues its previous vision and is working on regional end-to-end laboratories, testing service lines, testing quality control, improving its presence, and strengthening management controls. - FY2019-Q3RestatedAnnual report
「Fiscal 2018 was the first year of the Seventh Medium-Term Management Plan (fiscal 2018 to fiscal 2020). We have continued the group vision established under the Sixth Medium-Term Management Plan, “To become a company trusted and chosen by the medical community,” and continue to work to improve quality and services.」
As the first year of the Seventh Medium-Term Management Plan, the company continues its previous Group vision and is working to improve quality and services. - FY2019-Q2RestatedAnnual report
「Fiscal 2018 was the first year of the Seventh Medium-Term Management Plan (fiscal 2018 to fiscal 2020). We have continued the group vision established under the Sixth Medium-Term Management Plan, “To become a company trusted and chosen by the medical community,” and continue to work to improve quality and services.」
As the first year of the Seventh Medium-Term Management Plan, the company continues its previous Group vision and is working to improve quality and services. - FY2019-Q1ReframedAnnual report
「Fiscal 2018 was the first year of the Seventh Medium-Term Management Plan (fiscal 2018 to fiscal 2020). We have continued the group vision established under the Sixth Medium-Term Management Plan, “To become a company trusted and chosen by the medical community,” and continue to work to improve quality and services.」
The company changed from the Sixth Medium-Term Management Plan to the Seventh Medium-Term Management Plan (fiscal 2018 to fiscal 2020). The Group vision continues, but this filing does not restate the specific details of the previous four foundations. - FY2018-Q3RestatedAnnual report
「For us, fiscal 2017 was the final year of the Sixth Medium-Term Management Plan (fiscal 2015 to fiscal 2017). We continue to work to improve quality and services in order to achieve our vision of becoming a company trusted and chosen by the medical community.」
As the final year of the Sixth Medium-Term Management Plan, the company continues to improve quality and services toward achieving its vision. - FY2018-Q2RestatedAnnual report
「For us, fiscal 2017 was the final year of the Sixth Medium-Term Management Plan (fiscal 2015 to fiscal 2017). We continue to work to improve quality and services in order to achieve our vision of becoming a company trusted and chosen by the medical community.」
As the final year of the Sixth Medium-Term Management Plan, the company continues to improve quality and services toward achieving its vision. - FY2018-Q1RestatedAnnual report
「For us, fiscal 2017 was the final year of the Sixth Medium-Term Management Plan (fiscal 2015 to fiscal 2017). We continue to work to improve quality and services in order to achieve our vision of becoming a company trusted and chosen by the medical community.」
As the final year of the Sixth Medium-Term Management Plan, the company continues to improve quality and services toward achieving its vision. - FY2017First statedAnnual report
「Fiscal 2017 is the final year of the Sixth Medium-Term Management Plan (fiscal 2015 to fiscal 2017). Under the Sixth Medium-Term Management Plan, the company has adopted the vision of “Becoming a company trusted and chosen by the medical community” and is addressing various challenges aimed at creating a new company. Under the concept of “Building and strengthening the foundations as an industry-leading company,” it is advancing the “strengthening of the sales foundation,” “expansion of the testing foundation,” and “rebuilding of the systems foundation” to improve quality and services. It has also identified “enhancing the human resources foundation” as the most important supporting priority and is working to educate and develop its personnel. In addition, it will strengthen management quality and functions to solidify its business foundation.」
As the final year of the Sixth Medium-Term Management Plan for fiscal 2015 to fiscal 2017, the company is advancing the strengthening of the four foundations—sales, testing, systems, and human resources—and management quality.